Immune evasive mechanisms contributing to persistent Leishmania donovani infection. - Wikidata - awgldk - TriplyDB

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

http://www.wikidata.org/entity/Q34093793

about

The immunology of post-kala-azar dermal leishmaniasis (PKDL)Cytokine profiles amongst Sudanese patients with visceral leishmaniasis and malaria co-infections.A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.BEI Resources: a biological resource center for parasitologists T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype.Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani Optimal control and cost-effective analysis of malaria/visceral leishmaniasis co-infection.Identification and Characterization of miRNAs in Response to Leishmania donovani Infection: Delineation of Their Roles in Macrophage Dysfunction Th9/IL-9 profile in human echinococcosis: their involvement in immune response during infection by Echinococcus granulosus Targeting Dendritic Cells as a Good Alternative to Combat Leishmania spp.

P2860

Q26739701-D4DDFFDB-8E9C-4E1F-B791-BCC59BF7FD73 Q33624814-B70D88CB-7F0E-4D32-939B-5DFDD556E2D8 Q33724960-BDAE914B-647F-4C10-9C9F-1F071F54D924 Q33749424-C03514BB-98DD-46AE-BADD-4346A3A914C5 Q34306354-72E4ECE4-BA57-4320-A352-4B5E917B2548 Q34795494-03FBB4DA-56DC-4A12-8C1F-0BB0B2F9C950 Q35120056-99114359-9E0D-4336-A7C2-6889A6033DF2 Q35909887-9482A112-F2F8-4EEA-AADB-DE08F8CBD8EE Q36271850-1D38B8EF-FB51-4FB8-A61C-C482B0A5E732 Q37675397-5D63B992-FCB2-4DFF-B9DA-580ED5E05493 Q37700776-EDB77EDF-72F2-466A-A736-6D601FFE6201 Q38287969-853371BC-4BD3-4953-883E-678359E8DD10

P2860

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

http://www.wikidata.org/entity/Q34093793

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@ast

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@en

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@nl

type

label

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@ast

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@en

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@nl

prefLabel

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@ast

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@en

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@nl

P1433

Q34093793-E572CD04-72D0-442A-8344-943D0367ED97

P1476

Q34093793-3EFF6A84-1ADE-4968-97B4-167925211D05

P2093

Q34093793-1001E300-D9BC-4A58-BDF9-63741D00B60B

Q34093793-6CFF73B9-3051-4569-B41C-36C8AC7B6FFF

Q34093793-88579CB7-1FD0-44E4-8B04-8AD91805C42C

P2860

Q34093793-09A1F70E-4EEC-4C89-8516-29648D9B673A

Q34093793-0DC7FB0F-CB7B-4FDD-ACD1-36485183D3DC

Q34093793-0FCB6232-FFBC-4DEF-85E2-DD683136D172

Q34093793-12DE1B11-2E14-4BEB-8BB5-8A352F0AF557

Q34093793-202D1BDF-660E-4F27-A1A7-560C04E581F6

Q34093793-41368C52-9C70-4879-B803-ECF5CEC9916A

Q34093793-47E8ED1E-E3ED-4721-8C8E-71C9855B61D1

Q34093793-52F3E355-88AB-4E07-B480-25FEEE61C085

Q34093793-67B0FA83-DFEE-455B-88BF-808B238308A7

Q34093793-6A7C468B-D871-4E55-BCAC-74FD9A98F371

P2888

Q34093793-3318D547-6219-4C55-A39C-6B98C84C5D54

P304

Q34093793-90728D05-BA3D-47A1-8764-B3F09EA1E055

P31

Q34093793-5E470E4E-255E-4794-BC01-4FE6AD21467E

P356

Q34093793-3F8EB93E-B362-4723-B62C-E42877D36F25

P433

Q34093793-66166F2E-F283-4682-A688-3EA920D3C195

P478

Q34093793-DDD68EF7-3F4C-4337-BF31-0B0FBDFA10A1

P577

Q34093793-CDC2D09E-FB21-4C89-9DD2-BAC7F7474E10

P6179

Q34093793-0A29D10D-FB89-4C99-9B98-9037DA6B99D7

P698

Q34093793-B95AABEA-ECA2-436C-95A2-779D084E1B0F

P356

S12026-009-8135-4

P1433

Immunologic Research

P1476

Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

@en

P2093

Rashmi Bankoti

http://www.w3.org/2001/XMLSchema#string

Simona Stäger

http://www.w3.org/2001/XMLSchema#string

Trupti Joshi

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model

A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.

Modulation of dendritic cell function by Leishmania parasites

IL-10: the master regulator of immunity to infection.

Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses.

Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections.

B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology.

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.

Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts.

P2888

s12026-009-8135-4

P304

14-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12026-009-8135-4

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033790900

http://www.w3.org/2001/XMLSchema#string

P698

20087685

http://www.w3.org/2001/XMLSchema#string